Loading…

Concomitant thyroid Malt lymphoma and papillary thyroid carcinoma

The objective of this study was to describe the rare thyroid MALT lymphoma concomitant with papillary thyroid carcinoma in a male patient who was submitted to total thyroidectomy. Treatment and follow-up issues are addressed. Male patient complains of fast thyroid enlargement without lymphadenophaty...

Full description

Saved in:
Bibliographic Details
Published in:Arquivos brasileiros de endocrinologia e metabologia 2010-06, Vol.54 (4), p.425-428
Main Authors: Melo, Giulianno Molina de, Sguilar, Danilo Anunciatto, Petiti, Cyntia Moniz Figueira, Eichstaedt, André Gustavo Gumz, Caiado, Rogério Ramos, Souza, Ricardo Antenor de Souza E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective of this study was to describe the rare thyroid MALT lymphoma concomitant with papillary thyroid carcinoma in a male patient who was submitted to total thyroidectomy. Treatment and follow-up issues are addressed. Male patient complains of fast thyroid enlargement without lymphadenophaty and normal clinical exams. Total thyroidectomy was indicated and performed without any complications. The pathology showed multicentric papillary thyroid carcinoma, concomitant thyroid MALT lymphoma and Hashimoto's thyroiditis. The immunohistochemistry assay was positive for CD 20, CD 43, CD 79, AE1/AE3. The staging studies showed no evidence of both metastasis, Ann Harbor stage IE, without B symptoms. After RIT no further radiotherapy or chemotherapy was indicated. Nowadays the thyroglobulin is undetectable, without recurrences at two years of follow-up. It was concluded that primary thyroid MALT lymphoma is uncommon being the papillary thyroid carcinoma more frequent. Both occurring concomitantly is very rare and the treatment has to prioritize the tumor of worst prognosis at the discovery moment.
ISSN:0004-2730
1677-9487
1677-9487
0004-2730
DOI:10.1590/s0004-27302010000400013